Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mead Johnson

This article was originally published in The Tan Sheet

Executive Summary

GRAS notice for arachidonic acid-rich single-cell oil does not imply oils will be added to infant formulas in U.S., BMS subsidiary says. Notice, filed with FDA Aug. 6, would allow Mead to provide ARASCO in term infant formula at maximum level of 1.88% of total dietary fat when used in combination with docosahexaenoic acid-rich single-cell oil at maximum level of 1.25% and at a ratio ranging from 1:1 to 1:2. Although Martek Biosciences received GRAS nod from FDA for its ARA and DHA oils in May, levels did not cover amounts Mead adds to formulas sold in Asia and Europe. Enfamil maker has a licensing agreement with Martek, but says it has no plans to add the oils to formulas in the U.S
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS093087

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel